Kirin Holdings Company, Limited

2503

JP3258000003

Kirin Holdings Company, Limited is a holding company organized around 3 areas of activity: - production of beverages (61.6% of net sales): beers, wines and liqueurs (brands Budweiser, Guinness, Heineken, Franzia, Frontera, etc.), carbonated beverages (brands Kirin Lemon), fruit juices (Kirin Tropicana), mineral water (Volvic and Kirin Alkali-Ion-no-Mizu), coffees (Kirin Fire), teas (Kirin Gogo-no-kocha), dairy products etc.; - manufacturing of pharmaceutical products (19.3%): especially for anemia and allergies treatment; - other (19.1%) : mainly manufacturing of food products (seasonings, food additives, etc.). Net sales break down geographically as follows: Japan (64.1%), Oceania (9.6%), America (17.5%) and other (8.8%).

Sector

Brewers

Calendar

2024-06-26 - Ex-dividend day for dividende intermédiaire

Related indices

Nikkei 225

More about the company

Income Statement Evolution

More financial data

Ratings for Kirin Holdings Company, Limited

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

2,228 JPY

Average target price

2,288 JPY

Spread / Average Target

+2.69%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Brewers

	1st Jan change	Capi.
KIRIN HOLDINGS COMPANY, LIMITED	+9.05%	11.65B
ANHEUSER-BUSCH INBEV SA/NV	+4.25%	135B
HEINEKEN N.V.	+3.15%	59.38B
CONSTELLATION BRANDS, INC.	+4.36%	46.16B
AMBEV S.A.	-10.34%	37.83B
HEINEKEN HOLDING N.V.	+2.22%	24.01B
CARLSBERG A/S	+16.27%	19.86B
BUDWEISER BREWING COMPANY APAC LIMITED	-22.85%	18.9B
ASAHI GROUP HOLDINGS, LTD.	+12.21%	19.02B
CHINA RESOURCES BEER (HOLDINGS) COMPANY LIMITED	+8.63%	15.68B

Other Brewers

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-16 am EDT			5-day change	1st Jan Change
2,253 ^JPY	+1.14%		+0.33%	+9.05%

May. 10	Kirin Holdings' Attributable Profit Surges 363% in Fiscal Q1	MT
May. 08	Kirin Holdings Company, Limited and National Institute of Infectious Diseases Jointly Conducts Studies to Investigate the Protective Efficacy of LC-Plasma-Based Vaccine Research Selected for SCARDA Project	CI

Kirin Holdings' Attributable Profit Surges 363% in Fiscal Q1	May. 09	MT
Kirin Holdings Company, Limited and National Institute of Infectious Diseases Jointly Conducts Studies to Investigate the Protective Efficacy of LC-Plasma-Based Vaccine Research Selected for SCARDA Project	May. 07	CI
Nightingale Health Closes Purchase of Japan's Welltus	Mar. 29	MT
Nightingale Health Oyj completed the acquisition of Welltus Inc from Mitsui & Co., Ltd. and Kirin Holdings Company, Limited.	Mar. 28	CI
Finland-based Nightingale Health to Buy Japan's Welltus	Mar. 07	MT
Nightingale Health Oyj agreed to acquire Welltus Inc from Mitsui & Co., Ltd. and Kirin Holdings Company, Limited.	Mar. 06	CI
B9 Beverages Private Limited announced that it has received INR 4.14086 billion in funding from Tiger Pacific Capital LP, Kirin Holdings Company, Limited	Mar. 05	CI
B9 Beverages Private Limited announced that it expects to receive INR 4.14086 billion in funding Kirin Holdings Company, Limited	Feb. 19	CI
Kirin's Profit Up 1.5% in Fiscal 2023	Feb. 14	MT
Japan's Kirin names executive Minakata as new president	Feb. 14	RE
Japan's Kirin to name executive Takeshi Minakata as new president - Nikkei	Feb. 14	RE
Kirin sees Japan whisky 'renaissance' driving 50% export of premium brand	Jan. 24	RE
'Daigou' goes corporate as retailers seek new ways to reach Chinese shoppers	Dec. 20	RE
Japanese whisky turns 100 as craft distilleries transform industry	Nov. 20	RE
Kirin Logs Lower Nine-Month Attributable Profit Amid Increased Costs	Nov. 08	MT
L Catterton Partners completed the acquisition of Thorne HealthTech, Inc. from Mitsui & Co., Ltd., Kirin Holdings Company, Limited, Helsinn Therapeutics (U.S.), Inc., Diversified Natural Products, Inc. and others.	23-10-15	CI
L Catterton Partners entered into a definitive agreement to acquire Thorne HealthTech, Inc. from Mitsui & Co., Ltd., Kirin Holdings Company, Limited, Helsinn Therapeutics (U.S.), Inc., Diversified Natural Products, Inc. and others for approximately $620 million.	23-08-27	CI
Kirin Holdings’ Proceeds with Blackmore’s Acquisition for AU$1.88 Billion or 169.2 Billion Yen	23-08-14	MT
Kirin Holdings Reports 42.2% Drop in H1 Attributable Profit; Shares Slump 6%	23-08-08	MT
Kirin Holdings Company, Limited Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023	23-08-08	CI
At-home health test maker Thorne explores sale -sources	23-07-21	RE
At-home health test maker Thorne explores sale-sources	23-07-21	RE
Blackmores Acquisition by Kirin Holdings Takes Legal Effect	23-07-21	MT
Nomura Adjusts Kirin's Price Target to 2,850 Yen From 2,750 Yen, Keeps at Buy	23-05-31	MT
Kirin's Q1 Attributable Profit Drops 68%	23-05-15	MT